119 related articles for article (PubMed ID: 202282)
1. Phosphodiesterase in the liver fluke, Fasciola hepatica.
Mansour TE; Mansour JM
Biochem Pharmacol; 1977 Dec; 26(24):2325-30. PubMed ID: 202282
[No Abstract] [Full Text] [Related]
2. Cyclic AMP phosphodiesterase activity in Fasciola hepatica (L.) homogenates.
Simonic T; Sartyorelli P; Locatelli A
Ann Parasitol Hum Comp; 1975; 50(4):461-8. PubMed ID: 174476
[TBL] [Abstract][Full Text] [Related]
3. Rod outer segment phosphodiesterase: factors affecting the hydrolysis of cyclic-AMP and cyclic-GMP.
Chader G; Fletcher R; Johnson M; Bensinger R
Exp Eye Res; 1974 Jun; 18(6):509-15. PubMed ID: 4369151
[No Abstract] [Full Text] [Related]
4. Effect of some phosphodiesterase inhibitors on adenylate cyclase from the liver fluke, Fasciola hepatica.
Mansour TE; Mansour JM
Biochem Pharmacol; 1979 Jun; 28(12):1943-6. PubMed ID: 88227
[No Abstract] [Full Text] [Related]
5. Regulation of cyclic nucleotide phosphodiesterases of cerebral cortex by Ca2+ and cyclic GMP.
Filburn CR; Colpo F; Sacktor B
J Neurochem; 1978 Feb; 30(2):337-46. PubMed ID: 203661
[No Abstract] [Full Text] [Related]
6. Current landscape of phosphodiesterase 10A (PDE10A) inhibition.
Chappie TA; Helal CJ; Hou X
J Med Chem; 2012 Sep; 55(17):7299-331. PubMed ID: 22834877
[No Abstract] [Full Text] [Related]
7. Histochemical evidence of cyclic nucleotide phosphodiesterase in photoreceptor outer segments.
Robb RM
Invest Ophthalmol; 1974 Oct; 13(10):740-7. PubMed ID: 4370068
[No Abstract] [Full Text] [Related]
8. [Cyclic nucleotides phosphodiesterases inhibitors].
Hagiwara M; Hidaka H
Nihon Rinsho; 1991 Sep; 49(9):1993-8. PubMed ID: 1660084
[No Abstract] [Full Text] [Related]
9. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
Manganiello V
Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
[No Abstract] [Full Text] [Related]
10. Adenosine cyclic 3',5'-monophosphate in the liver fluke, Fasciola hepatica. I. Activation of adenylate cyclase by 5-hydroxytryptamine.
Abrahams SL; Northup JK; Mansour TE
Mol Pharmacol; 1976 Jan; 12(1):49-58. PubMed ID: 176567
[No Abstract] [Full Text] [Related]
11. Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.
Harris DN; Chasin M; Phillips MB; Goldenberg H; Samaniego S; Hess SM
Biochem Pharmacol; 1973 Jan; 22(2):221-8. PubMed ID: 4357795
[No Abstract] [Full Text] [Related]
12. Adenosine cyclic 3',5'-monophosphate in the liver fluke, Fasciola hepatica. II. Activation of protein kinase by 5-hydroxytryptamine.
Gentleman S; Abrahams SL; Mansour TE
Mol Pharmacol; 1976 Jan; 12(1):59-68. PubMed ID: 176568
[No Abstract] [Full Text] [Related]
13. Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro.
Stief CG; Taher A; Truss M; Becker AJ; Schulz-Knappe P; Meyer M; Uckert S; Forssmann WG; Jonas U
Urol Int; 1995; 55(4):183-9. PubMed ID: 8588263
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase activity in muscles of control and dystrophic mice.
Garbagna L; Cojazzi M; Marcucci F; Mussini E
Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):537-44. PubMed ID: 6265991
[TBL] [Abstract][Full Text] [Related]
15. PDE inhibition and cognition enhancement.
Blokland A; Menniti FS; Prickaerts J
Expert Opin Ther Pat; 2012 Apr; 22(4):349-54. PubMed ID: 22475506
[No Abstract] [Full Text] [Related]
16. 1-Ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)--a potent new inhibitor of cyclic 3',5'-nucleotide phosphodiesterases.
Chasin M; Harris DN; Phillips MB; Hess SM
Biochem Pharmacol; 1972 Sep; 21(18):2443-50. PubMed ID: 4345859
[No Abstract] [Full Text] [Related]
17. Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions.
Davis CW
Biochim Biophys Acta; 1984 Mar; 797(3):354-62. PubMed ID: 6320906
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
19. Adenosine 3',5'-cyclic monophosphate phosphodiesterase in guinea-pig lung--properties and effect of adrenergic drugs.
Hitchcock M
Biochem Pharmacol; 1973 Apr; 22(8):959-69. PubMed ID: 4348394
[No Abstract] [Full Text] [Related]
20. The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family.
Gibson LC; Hastings SF; McPhee I; Clayton RA; Darroch CE; Mackenzie A; Mackenzie FL; Nagasawa M; Stevens PA; Mackenzie SJ
Eur J Pharmacol; 2006 May; 538(1-3):39-42. PubMed ID: 16674936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
